{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T04:33:16Z","timestamp":1772080396896,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T00:00:00Z","timestamp":1571356800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["31003A_156481"],"award-info":[{"award-number":["31003A_156481"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibroblast Growth Factor 23 (FGF23) is a phosphaturic factor causing increased renal phosphate excretion as well as suppression of 1,25 (OH)<jats:sub>2<\/jats:sub>-vitamin D<jats:sub>3.<\/jats:sub> Highly elevated FGF23 can promote development of rickets and osteomalacia. We and others previously reported that acute application of erythropoietin (EPO) stimulates FGF23 production. Considering that EPO is clinically used as chronic treatment against anemia, we used here the Tg6 mouse model that constitutively overexpresses human EPO in an oxygen-independent manner, to examine the consequences of long-term EPO therapy on mineral and bone metabolism. Six to eight weeks old female Tg6 mice showed elevated intact and C-terminal fragment of FGF23 but normal plasma levels of PTH, calcitriol, calcium and phosphate. Renal function showed moderate alterations with higher urea and creatinine clearance and mild albuminuria. Renal phosphate excretion was normal whereas mild hypercalciuria was found. Renal expression of the key proteins TRPV5 and calbindin D28k involved in active calcium reabsorption was reduced in Tg6 mice. Plasma levels of the bone turnover marker osteocalcin were comparable between groups. However, urinary excretion of deoxypyridinoline (DPD) was lower in Tg6 mice. MicroCT analysis showed reduced total, cortical, and trabecular bone mineral density in femora from Tg6 mice. Our data reveal that chronic elevation of EPO is associated with high FGF23 levels and disturbed mineral homeostasis resulting in reduced bone mineral density. These observations imply the need to study the impact of therapeutically applied EPO on bone mineralization in patients, especially those suffering from chronic kidney disease.<\/jats:p>","DOI":"10.1038\/s41598-019-51577-z","type":"journal-article","created":{"date-parts":[[2019,10,18]],"date-time":"2019-10-18T11:59:26Z","timestamp":1571399966000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Elevated FGF23 and disordered renal mineral handling with reduced bone mineralization in chronically erythropoietin over-expressing transgenic mice"],"prefix":"10.1038","volume":"9","author":[{"given":"Arezoo","family":"Daryadel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciano","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra","family":"Seebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Bettoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udo","family":"Schnitzbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Max","family":"Gassmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9874-8898","authenticated-orcid":false,"given":"Carsten A.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,18]]},"reference":[{"key":"51577_CR1","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.bone.2016.11.013","volume":"100","author":"OM Kuro","year":"2017","unstructured":"Kuro, O. M. & Moe, O. W. FGF23-alphaKlotho as a paradigm for a kidney-bone network. Bone 100, 4\u201318, https:\/\/doi.org\/10.1016\/j.bone.2016.11.013 (2017).","journal-title":"Bone"},{"key":"51577_CR2","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-physiol-030212-183727","volume":"75","author":"MC Hu","year":"2013","unstructured":"Hu, M. C., Shiizaki, K., Kuro-o, M. & Moe, O. W. Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolism. Annu Rev Physiol 75, 503\u2013533, https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183727 (2013).","journal-title":"Annu Rev Physiol"},{"key":"51577_CR3","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1126\/science.1114245","volume":"310","author":"Q Chang","year":"2005","unstructured":"Chang, Q. et al. The beta-glucuronidase klotho hydrolyzes and activates the TRPV5 channel. Science 310, 490\u2013493 (2005).","journal-title":"Science"},{"key":"51577_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1172\/JCI200419081","volume":"113","author":"T Shimada","year":"2004","unstructured":"Shimada, T. et al. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113, 561\u2013568 (2004).","journal-title":"J Clin Invest"},{"key":"51577_CR5","doi-asserted-by":"publisher","first-page":"F132","DOI":"10.1152\/ajprenal.00081.2017","volume":"314","author":"S Rabadi","year":"2018","unstructured":"Rabadi, S., Udo, I., Leaf, D. E., Waikar, S. S. & Christov, M. Acute blood loss stimulates fibroblast growth factor 23 production. Am J Physiol Renal Physiol 314, F132\u2013F139, https:\/\/doi.org\/10.1152\/ajprenal.00081.2017 (2018).","journal-title":"Am J Physiol Renal Physiol"},{"key":"51577_CR6","doi-asserted-by":"publisher","first-page":"3752","DOI":"10.1096\/fj.201700667R","volume":"32","author":"R Agoro","year":"2018","unstructured":"Agoro, R. et al. Inhibition of fibroblast growth factor 23 (FGF23) signaling rescues renal anemia. FASEB J 32, 3752\u20133764, https:\/\/doi.org\/10.1096\/fj.201700667R (2018).","journal-title":"FASEB J"},{"key":"51577_CR7","doi-asserted-by":"publisher","first-page":"9795","DOI":"10.1074\/jbc.M113.527150","volume":"289","author":"LM Coe","year":"2014","unstructured":"Coe, L. M. et al. FGF-23 is a negative regulator of prenatal and postnatal erythropoiesis. J Biol Chem 289, 9795\u20139810, https:\/\/doi.org\/10.1074\/jbc.M113.527150 (2014).","journal-title":"J Biol Chem"},{"key":"51577_CR8","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.3324\/haematol.2017.167882","volume":"102","author":"EL Clinkenbeard","year":"2017","unstructured":"Clinkenbeard, E. L. et al. Erythropoietin stimulates murine and human fibroblast growth factor-23, revealing novel roles for bone and bone marrow. Haematologica 102, e427\u2013e430, https:\/\/doi.org\/10.3324\/haematol.2017.167882 (2017).","journal-title":"Haematologica"},{"key":"51577_CR9","doi-asserted-by":"publisher","first-page":"e0186979","DOI":"10.1371\/journal.pone.0186979","volume":"12","author":"I Flamme","year":"2017","unstructured":"Flamme, I., Ellinghaus, P., Urrego, D. & Kruger, T. FGF23 expression in rodents is directly induced via erythropoietin after inhibition of hypoxia inducible factor proline hydroxylase. PLoS One 12, e0186979, https:\/\/doi.org\/10.1371\/journal.pone.0186979 (2017).","journal-title":"PLoS One"},{"key":"51577_CR10","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00424-018-2171-7","volume":"470","author":"A Daryadel","year":"2018","unstructured":"Daryadel, A. et al. Erythropoietin stimulates fibroblast growth factor 23 (FGF23) in mice and men. Pflugers Arch 470, 1569\u20131582, https:\/\/doi.org\/10.1007\/s00424-018-2171-7 (2018).","journal-title":"Pflugers Arch"},{"key":"51577_CR11","doi-asserted-by":"publisher","unstructured":"Toro, L. et al. Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injury. Kidney Int, https:\/\/doi.org\/10.1016\/j.kint.2017.11.018 (2018).","DOI":"10.1016\/j.kint.2017.11.018"},{"key":"51577_CR12","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1053\/j.ajkd.2015.06.030","volume":"67","author":"M Bonomini","year":"2016","unstructured":"Bonomini, M., Del Vecchio, L., Sirolli, V. & Locatelli, F. New Treatment Approaches for the Anemia of CKD. Am J Kidney Dis 67, 133\u2013142, https:\/\/doi.org\/10.1053\/j.ajkd.2015.06.030 (2016).","journal-title":"Am J Kidney Dis"},{"key":"51577_CR13","doi-asserted-by":"publisher","first-page":"11609","DOI":"10.1073\/pnas.97.21.11609","volume":"97","author":"FT Ruschitzka","year":"2000","unstructured":"Ruschitzka, F. T. et al. Nitric oxide prevents cardiovascular disease and determines survival in polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci USA 97, 11609\u201311613, https:\/\/doi.org\/10.1073\/pnas.97.21.11609 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"51577_CR14","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1113\/jphysiol.2010.196147","volume":"589","author":"J Vogel","year":"2011","unstructured":"Vogel, J. & Gassmann, M. Erythropoietic and non-erythropoietic functions of erythropoietin in mouse models. J Physiol 589, 1259\u20131264, https:\/\/doi.org\/10.1113\/jphysiol.2010.196147 (2011).","journal-title":"J Physiol"},{"key":"51577_CR15","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1182\/blood.V97.2.536","volume":"97","author":"KF Wagner","year":"2001","unstructured":"Wagner, K. F. et al. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin. Blood 97, 536\u2013542 (2001).","journal-title":"Blood"},{"key":"51577_CR16","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1095\/biolreprod.107.065532","volume":"78","author":"M Gassmann","year":"2008","unstructured":"Gassmann, M. et al. Abortion in mice with excessive erythrocytosis is due to impaired arteriogenesis of the uterine arcade. Biol Reprod 78, 1049\u20131057, https:\/\/doi.org\/10.1095\/biolreprod.107.065532 (2008).","journal-title":"Biol Reprod"},{"key":"51577_CR17","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1096\/fj.14-259085","volume":"29","author":"S Hiram-Bab","year":"2015","unstructured":"Hiram-Bab, S. et al. Erythropoietin directly stimulates osteoclast precursors and induces bone loss. FASEB J 29, 1890\u20131900, https:\/\/doi.org\/10.1096\/fj.14-259085 (2015).","journal-title":"FASEB J"},{"key":"51577_CR18","doi-asserted-by":"publisher","unstructured":"Vogel, J. et al. Transgenic mice overexpressing erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102, 2278\u20132284, https:\/\/doi.org\/10.1182\/blood-2003-01-0283.","DOI":"10.1182\/blood-2003-01-0283"},{"key":"51577_CR19","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1007\/s00424-018-2171-7","volume":"470","author":"A Daryadel","year":"2018","unstructured":"Daryadel, A. et al. Erythropoietin stimulates Fibroblast Growth Factor 23 (FGF23) in mice and men. Pfl\u00fcgers Arch 470, 1569\u20131582 (2018).","journal-title":"Pfl\u00fcgers Arch"},{"key":"51577_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bone.2014.07.022","volume":"68","author":"NH Kelly","year":"2014","unstructured":"Kelly, N. H., Schimenti, J. C., Patrick Ross, F. & van der Meulen, M. C. A method for isolating high quality RNA from mouse cortical and cancellous bone. Bone 68, 1\u20135, https:\/\/doi.org\/10.1016\/j.bone.2014.07.022 (2014).","journal-title":"Bone"},{"key":"51577_CR21","doi-asserted-by":"publisher","unstructured":"Daryadel, A. et al. Colocalization of the (Pro)renin Receptor\/Atp6ap2 with H+-ATPases in Mouse Kidney but Prorenin Does Not Acutely Regulate Intercalated Cell H+-ATPase Activity. PLoS One 11, e0147831, https:\/\/doi.org\/10.1371\/journal.pone.0147831.","DOI":"10.1371\/journal.pone.0147831"},{"key":"51577_CR22","doi-asserted-by":"publisher","first-page":"F767","DOI":"10.1152\/ajprenal.1994.266.5.F767","volume":"266","author":"M Custer","year":"1994","unstructured":"Custer, M., Lotscher, M., Biber, J., Murer, H. & Kaissling, B. Expression of Na-P(i) cotransport in rat kidney: localization by RT-PCR and immunohistochemistry. Am J Physiol 266, F767\u2013774, https:\/\/doi.org\/10.1152\/ajprenal.1994.266.5.F767 (1994).","journal-title":"Am J Physiol"},{"key":"51577_CR23","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1007\/s00424-014-1470-x","volume":"466","author":"EA van der Hagen","year":"2014","unstructured":"van der Hagen, E. A. et al. Coordinated regulation of TRPV5-mediated Ca(2)(+) transport in primary distal convolution cultures. Pflugers Arch 466, 2077\u20132087, https:\/\/doi.org\/10.1007\/s00424-014-1470-x (2014).","journal-title":"Pflugers Arch"},{"key":"51577_CR24","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/hep.26550","volume":"58","author":"V Diaz","year":"2013","unstructured":"Diaz, V. et al. Liver iron modulates hepcidin expression during chronically elevated erythropoiesis in mice. Hepatology 58, 2122\u20132132, https:\/\/doi.org\/10.1002\/hep.26550 (2013).","journal-title":"Hepatology"},{"key":"51577_CR25","doi-asserted-by":"publisher","first-page":"R330","DOI":"10.1152\/ajpregu.00410.2014","volume":"308","author":"E Gammella","year":"2015","unstructured":"Gammella, E. et al. Erythropoietin\u2019s inhibiting impact on hepcidin expression occurs indirectly. Am J Physiol Regul Integr Comp Physiol 308, R330\u2013335, https:\/\/doi.org\/10.1152\/ajpregu.00410.2014 (2015).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"51577_CR26","doi-asserted-by":"publisher","first-page":"R947","DOI":"10.1152\/ajpregu.00152.2006","volume":"291","author":"K Heinicke","year":"2006","unstructured":"Heinicke, K. et al. Excessive erythrocytosis in adult mice overexpressing erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am J Physiol Regul Integr Comp Physiol 291, R947\u2013956, https:\/\/doi.org\/10.1152\/ajpregu.00152.2006 (2006).","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"51577_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.kint.2018.02.017","volume":"94","author":"EM Pastor-Arroyo","year":"2018","unstructured":"Pastor-Arroyo, E. M. et al. The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk. Kidney Int 94, 49\u201359, https:\/\/doi.org\/10.1016\/j.kint.2018.02.017 (2018).","journal-title":"Kidney Int"},{"key":"51577_CR28","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/jbmr.2857","volume":"31","author":"M Rauner","year":"2016","unstructured":"Rauner, M. et al. Increased EPO Levels Are Associated With Bone Loss in Mice Lacking PHD2 in EPO-Producing Cells. J Bone Miner Res 31, 1877\u20131887, https:\/\/doi.org\/10.1002\/jbmr.2857 (2016).","journal-title":"J Bone Miner Res"},{"key":"51577_CR29","doi-asserted-by":"crossref","first-page":"439","DOI":"10.33549\/physiolres.932900","volume":"64","author":"I Zofkova","year":"2015","unstructured":"Zofkova, I. Bone tissue as a systemic endocrine regulator. Physiol Res 64, 439\u2013445 (2015).","journal-title":"Physiol Res"},{"key":"51577_CR30","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/1043-2760(92)90129-O","volume":"3","author":"MJ Seibel","year":"1992","unstructured":"Seibel, M. J., Robins, S. P. & Bilezikian, J. P. Urinary pyridinium crosslinks of collagen: specific markers of bone resorption in metabolic bone disease. Trends Endocrinol Metab 3, 263\u2013270 (1992).","journal-title":"Trends Endocrinol Metab"},{"key":"51577_CR31","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/j.1399-6576.2010.02369.x","volume":"55","author":"C Solling","year":"2011","unstructured":"Solling, C. et al. Erythropoietin administration is associated with short-term improvement in glomerular filtration rate after ischemia-reperfusion injury. Acta Anaesthesiol Scand 55, 185\u2013195, https:\/\/doi.org\/10.1111\/j.1399-6576.2010.02369.x (2011).","journal-title":"Acta Anaesthesiol Scand"},{"key":"51577_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1248\/jhs.50.343","volume":"50","author":"K Uzuner","year":"2004","unstructured":"Uzuner, K., Yazihan, N., Aydin, Y., Uyar, R. & Bagla, S. Acute erythropoietin infusion increases rat glomerular filtration rate by partly stimulating intrarenal nitric oxide production. J Health Sci 50, 343\u2013347 (2004).","journal-title":"J Health Sci"},{"key":"51577_CR33","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1681\/ASN.2010121316","volume":"22","author":"AH Arestegui","year":"2011","unstructured":"Arestegui, A. H. et al. High altitude renal syndrome (HARS). J Am Soc Nephrol 22, 1963\u20131968, https:\/\/doi.org\/10.1681\/ASN.2010121316 (2011).","journal-title":"J Am Soc Nephrol"},{"key":"51577_CR34","doi-asserted-by":"publisher","unstructured":"Hanudel, M. R. et al. Effects of erythropoietin on fibroblast growth factor 23 in mice and humans. Nephrol Dial Transplant, https:\/\/doi.org\/10.1093\/ndt\/gfy189 (2018).","DOI":"10.1093\/ndt\/gfy189"},{"key":"51577_CR35","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1038\/ki.2013.526","volume":"85","author":"D Spichtig","year":"2014","unstructured":"Spichtig, D. et al. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease. Kidney Int 85, 1340\u20131350, https:\/\/doi.org\/10.1038\/ki.2013.526 (2014).","journal-title":"Kidney Int"},{"key":"51577_CR36","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1093\/ndt\/gfw376","volume":"32","author":"S Bansal","year":"2017","unstructured":"Bansal, S. et al. Spleen contributes significantly to increased circulating levels of fibroblast growth factor 23 in response to lipopolysaccharide-induced inflammation. Nephrol Dial Transplant 32, 960\u2013968, https:\/\/doi.org\/10.1093\/ndt\/gfw376 (2017).","journal-title":"Nephrol Dial Transplant"},{"key":"51577_CR37","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/08977194.2016.1273222","volume":"34","author":"Y Nakashima","year":"2016","unstructured":"Nakashima, Y. et al. Expression and localization of fibroblast growth factor (FGF)23 and Klotho in the spleen: its physiological and functional implications. Growth Factors 34, 196\u2013202, https:\/\/doi.org\/10.1080\/08977194.2016.1273222 (2016).","journal-title":"Growth Factors"},{"key":"51577_CR38","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1210\/jc.2018-00123","volume":"103","author":"F Bienaime","year":"2018","unstructured":"Bienaime, F. et al. Hepatic Production of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease. J Clin Endocrinol Metab 103, 2319\u20132328, https:\/\/doi.org\/10.1210\/jc.2018-00123 (2018).","journal-title":"J Clin Endocrinol Metab"},{"key":"51577_CR39","doi-asserted-by":"publisher","first-page":"E1146","DOI":"10.1073\/pnas.1110905108","volume":"108","author":"EG Farrow","year":"2011","unstructured":"Farrow, E. G. et al. Iron deficiency drives an autosomal dominant hypophosphatemic rickets (ADHR) phenotype in fibroblast growth factor-23 (Fgf23) knock-in mice. Proc Natl Acad Sci USA 108, E1146\u20131155, https:\/\/doi.org\/10.1073\/pnas.1110905108 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"51577_CR40","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/jbmr.1923","volume":"28","author":"M Wolf","year":"2013","unstructured":"Wolf, M., Koch, T. A. & Bregman, D. B. Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. J Bone Miner Res 28, 1793\u20131803, https:\/\/doi.org\/10.1002\/jbmr.1923 (2013).","journal-title":"J Bone Miner Res"},{"key":"51577_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1038\/nrneph.2009.100","volume":"5","author":"TE Woudenberg-Vrenken","year":"2009","unstructured":"Woudenberg-Vrenken, T. E., Bindels, R. J. & Hoenderop, J. G. The role of transient receptor potential channels in kidney disease. Nat Rev Nephrol 5, 441\u2013449, https:\/\/doi.org\/10.1038\/nrneph.2009.100 (2009).","journal-title":"Nat Rev Nephrol"},{"key":"51577_CR42","doi-asserted-by":"publisher","first-page":"9805","DOI":"10.1073\/pnas.0803223105","volume":"105","author":"SK Cha","year":"2008","unstructured":"Cha, S. K. et al. Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1. Proc Natl Acad Sci USA 105, 9805\u20139810, https:\/\/doi.org\/10.1073\/pnas.0803223105 (2008).","journal-title":"Proc Natl Acad Sci USA"},{"key":"51577_CR43","doi-asserted-by":"publisher","first-page":"35849","DOI":"10.1074\/jbc.M114.616649","volume":"289","author":"MT Wolf","year":"2014","unstructured":"Wolf, M. T., An, S. W., Nie, M., Bal, M. S. & Huang, C. L. Klotho up-regulates renal calcium channel transient receptor potential vanilloid 5 (TRPV5) by intra- and extracellular N-glycosylation-dependent mechanisms. J Biol Chem 289, 35849\u201335857, https:\/\/doi.org\/10.1074\/jbc.M114.616649 (2014).","journal-title":"J Biol Chem"},{"key":"51577_CR44","doi-asserted-by":"publisher","unstructured":"Chen, G. et al. alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling. Nature, https:\/\/doi.org\/10.1038\/nature25451 (2018).","DOI":"10.1038\/nature25451"},{"key":"51577_CR45","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1093\/ndt\/gfs460","volume":"28","author":"I Pavik","year":"2013","unstructured":"Pavik, I. et al. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Nephrol Dial Transplant 28, 352\u2013359, https:\/\/doi.org\/10.1093\/ndt\/gfs460 (2013).","journal-title":"Nephrol Dial Transplant"},{"key":"51577_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.cyto.2016.01.008","volume":"89","author":"S Hiram-Bab","year":"2017","unstructured":"Hiram-Bab, S., Neumann, D. & Gabet, Y. Erythropoietin in bone - Controversies and consensus. Cytokine 89, 155\u2013159, https:\/\/doi.org\/10.1016\/j.cyto.2016.01.008 (2017).","journal-title":"Cytokine"},{"key":"51577_CR47","doi-asserted-by":"publisher","unstructured":"Kn\u00f6pfel, T. et al. The intestinal phosphate transporter NaPi-IIb (Slc34a2) is required to protect bone during dietary phosphate restriction. Sci Rep 7, 11018, https:\/\/doi.org\/10.1038\/s41598-017-10390-2.","DOI":"10.1038\/s41598-017-10390-2"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51577-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51577-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51577-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T14:44:27Z","timestamp":1671288267000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-51577-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,18]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["51577"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-51577-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,18]]},"assertion":[{"value":"21 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14989"}}